BTIG Maintains Their Hold Rating on Masimo Corp (MASI)

By Jason Carr

BTIG analyst Sean Lavin maintained a Hold rating on Masimo Corp (MASIResearch Report) yesterday. The company’s shares closed yesterday at $157.85, close to its 52-week high of $160.25.

According to, Lavin is a 4-star analyst with an average return of 5.3% and a 56.1% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings Inc, Helius Medical Technologies, and Tactile Systems Technology.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Masimo Corp with a $165.75 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $160.25 and a one-year low of $98.23. Currently, Masimo Corp has an average volume of 413.3K.

Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MASI in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories.